基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
主要从事“免疫细胞功能调控与肿瘤免疫治疗新策略研发”领域的研究。以第一作者或共同第一作者在Nat Cell Biol、Cell Mol Immunol、Elife、Cell Death Dis、Cell Rev Allergy Immunol.等期刊发表文章数篇,总引用率>900次。课题组针对肿瘤免疫治疗领域重要的挑战:缺乏新靶点和新策略展开研究,研发肿瘤免疫治疗新机制和新方法,合成新靶点药物,并鉴定新的ICB治疗疗效预测的有效生物学标志物。团队与多家医院和药企合作,共同推进肿瘤免疫治疗的产业化。
Research Interests
Papers共 24 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Xiaoxuan Tu, Longxian Chen,Yi Zheng,Chenglin Mu,Zhiwei Zhang, Feiyu Wang, Yiqing Ren, Yingxin Duan,Hangyu Zhang,Zhou Tong,Lulu Liu, Xunqi Sun,
Lijing Wang,Shuchen Gu,Fenfang Chen,Yi Yu,Jin Cao,Xinran Li,Chun Gao,Yanzhen Chen,Shuchong Yuan,Xia Liu, Jun Qin,Bin Zhao,
Signal Transduction and Targeted Therapyno. 1 (2023): 1-14
Advanced Scienceno. 27 (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn